Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. newborn infant
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Newborn Infant Articles & Analysis

9 news found

CD BioGlyco Introduces HMOs Separation Service for Glycobiology Study

CD BioGlyco Introduces HMOs Separation Service for Glycobiology Study

Human milk is the best food for newborns and developing infants, and its unique function is irreplaceable by other dairy products. ...

ByCD BioGlyco.


EBR Systems Raises AU$110M in Initial Public Offering on the Australian Securities Exchange (ASX)

EBR Systems Raises AU$110M in Initial Public Offering on the Australian Securities Exchange (ASX)

The world’s first pacemaker was made in Sydney in 1929 and successfully used to resuscitate a newborn infant in 1929.ii EBR Systems’ WiSE Technology EBR Systems’ WiSE™ CRT System is the world’s only wireless, endocardial (inside the heart) pacing system in clinical use for stimulating the heart’s left ventricle. ...

ByEBR Systems, Inc.


Recent microbiome study finds that Intus Bio’s products differentiate closely related gut bacteria in premature infants

Recent microbiome study finds that Intus Bio’s products differentiate closely related gut bacteria in premature infants

Products from Intus Biosciences demonstrated high-resolution tracking of specific bacterial strains in a recent microbiome study, the results of which are being applied to better understand how pathogens and commensals become established in premature infants in neonatal intensive care units (NICU), with the goal of improving outcomes for premature infants. Intus Biosciences is a microbiome ...

ByIntus Biosciences, LLC


Bio-Me and Siolta Therapeutics to collaborate on developing microbiome-based pediatric allergy and asthma test

Bio-Me and Siolta Therapeutics to collaborate on developing microbiome-based pediatric allergy and asthma test

It is estimated that 30 – 35% of infants in the US are born into families with a history of allergy and asthma. This constitutes around 1.3 million infants annually who are typically considered to be associated with an increased risk. ...

ByBio-Me


Bio-Me and Siolta Therapeutics to collaborate on developing microbiome-based pediatric allergy and asthma test

Bio-Me and Siolta Therapeutics to collaborate on developing microbiome-based pediatric allergy and asthma test

It is estimated that 30 – 35% of infants in the US are born into families with a history of allergy and asthma. This constitutes around 1.3 million infants annually who are typically considered to be associated with an increased risk. ...

BySiolta Therapeutics


Kephera Diagnostics awarded Phase II grant from the National Institute of Allergy and Infectious Diseases (NAID) for Zika virus test

Kephera Diagnostics awarded Phase II grant from the National Institute of Allergy and Infectious Diseases (NAID) for Zika virus test

The arrival and rapid spread of Zika virus in the Western Hemisphere led to an epidemic in 2015-2016 that infected up to 1 million people, with serious consequences, including microcephaly in newborn infants and Guillain-Barré and other neurological disorders. ...

ByKephera Diagnostics, LLC


New study:  Nine out of ten U.S. infants experience gut microbiome deficiency

New study: Nine out of ten U.S. infants experience gut microbiome deficiency

A new peer-reviewed study reveals that the vast majority of U.S. infants may be suffering from a substantial deficiency in an important bacterium key to breast milk utilization and immune system development, as well as protection against gut pathogens linked to common newborn conditions such as colic and diaper rash. ...

ByEvolve BioSystems, Inc.


Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson & Johnson

Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson & Johnson

Third Pole Therapeutics, a privately held company developing and delivering transformative cardio-pulmonary therapies, announced today that it has entered into a strategic collaboration to work with Actelion Pharmaceuticals Ltd, a Janssen pharmaceutical company of Johnson & Johnson. The collaboration will bring the global resources and know-how of the largest and most respected healthcare ...

ByThird Pole Therapeutics, Inc.


Infants at greater risk from food packaging chemical

Infants at greater risk from food packaging chemical

In 2008, both Canada and the USA raised concerns over the possible harmful effects of BPA on newborns and infants. BPA is used to make a variety of common products including baby bottles, as well as the linings of food and drinks cans. ...

ByEuropean Commission, Environment DG

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT